We narrowed to 561 results for: ESC;

...post-translational level, unlike most of the other mechanisms described. Fig. 3 dTag mechanism of protein degradation...

... interactions in events that occur on a short timescale, such as during drug action or cell signaling....

...when applicable Any other relevant information Prescribing an official name to all of our plates, tubes,...

...Addgene’s blog Antibodies 101: Introduction to Immunofluorescence Antibodies 101: ELISAs Antibodies 101: Introduction...

...miniature CRISPR-Cas12f nuclease Quanjiang Ji’s lab describes an effective miniature Cas system that utilizes...

...candidate genes in TS iPSCs to identify whether any rescue cell migration and contraction defects. The lab...

...to receive deposits of plasmids that have been described in a preprint. In fact, over 1,500 plasmids in...

...Maybe I needed to employ a visual aid instead of describing something verbally. Sometimes a group was just...

...recombinant antibody plasmid collection References Grumezescu, A. M. (2018). Drug targeting and stimuli sensitive...

...driglar.     References 1. Alberts, Bruce, et al. "Rescuing US biomedical research from its systemic flaws...

...In early 2011, the Bogdanove and Voytas groups described a new Golden Gate-based technology for genome ...

...down your own results; are they the same as the description the authors give? Ask yourself if the results...

... Combining this with some of the loxP methods described above, a genetic modification can be restricted...

...cardiovascular disease, cholesterol gallstone disease, senescent illnesses, and the metabolic syndrome. Coregulators...

...types of data for each of their plasmids, from descriptions of key components of the plasmids to partial...

...but this also allows certain unintended edits to escape cellular surveillance. To limit unintended incorporation...

...Wen, B., Kraus, C., Miller, N. W., Steger, R. J., Escude Velasco, B., Bosch, J. A., Zirin, J. D., Viswanatha...

...Between SpRY and several of the other Cas variants described, nearly all genomic landscapes should be editable...

...Roth's and Takafumi Minamimoto's lab called deschloroclozapine (DCZ) shows promise as a CNO alternative ...

..., can accommodate large transgenes, transduce quiescent and dividing cells, and do not integrate into ...